Clinical implications of PCP, NMDA and opiate receptors.
Wilkins
J
J
Clinical Psychopharmacology Unit, Los Angeles VA Medical Center, Brentwood Division.
D000818:Animals; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects*; D006801:Humans; D010622:Phencyclidine / Q000009:adverse effects; D010623:Phencyclidine Abuse / Q000523:psychology*; D011605:Psychoses, Substance-Induced / Q000523:psychology; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter / Q000187:drug effects*; D011957:Receptors, Opioid / Q000187:drug effects*; D017478:Receptors, Phencyclidine; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D014754:Violence
D014150:Antipsychotic Agents; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter; D011957:Receptors, Opioid; D017478:Receptors, Phencyclidine; D010622:Phencyclidine